EP0504807A1
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Use of bis-(p-hydroxyphenylthio)methane derivatives to inhibit progressive development of insulin-dependent diabetes mellitus
Assignee: Aventis Pharmaceuticals Inc
•
Filing: 1992-03-17
•
Granted: —
•
Expires: 2012-03-17
Abstract
Abstract The present invention relates to a method of inhibiting the progressive development of insulin-dependent diabetes mellitus in a patient comprising administering to said patient an effective inhibitory amount of a compound of the formula wherein R₁, R₂, R₃ and R₄ are each independently a C₁-C₆ alkyl group.
Inventors
- 👤 Keith M. Robinson
- 👤 Richard L. Jackson
- 👤 Eric W. Heineke
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-10-25 06:52
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/28; A61K31/29; A61K31/095; A61K31/10; A61P; A61P3/00; A61P3/08; A61P3/10
Claims Analysis
Total Claims: 3
Claim 1
Independent Claim
44 words
A method for the preparation of a pharmaceutical composition useful in inhibiting the progressive development of insulin-dependent diabetes mellitus comprising combining a compound of the formula wherein R₁, R₂, R₃ and R₄ are each independently a C₁-C₆ alkyl group with a pharmaceutically acceptable carrier.
Claim 2
Independent Claim
52 words
A method for the preparation of a pharmaceutical composition useful in inhibiting the destruction of insulin-secreting islet β-cells caused by the progressive development of insulin-dependent diabetes mellitus, comprising combining a compound of the formula wherein R₁, R₂, R₃ and R₄ are each independently a C₁-C₆ alkyl group with a pharmaceutically acceptable carrier.
Claim 3
Dependent Claim
12 words
A method of Claim 1 or 2 wherein the compound is bis(3,5-di-tertiarybutyl-4-hydroxyphenylthio)methane.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.